Banys Valdas
Vilnius University, Faculty of Medicine, Institute of Biomedical Sciences, Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Vilnius, Lithuania.
Vilnius University Hospital Santaros Klinikos, Center of Laboratory Medicine, Vilnius, Lithuania.
EJIFCC. 2020 Nov 20;31(4):320-325. eCollection 2020 Nov.
The MedTech Europe Code of Ethical Business Practice came into effect on 1 January 2018. It was created by the medical technology industry. It addresses the importance of fair management of educational grants: public disclosure of provided educational grants, compliance of conferences with the Conference Vetting System; allocation of grants to healthcare organizations (HCOs) but not to the healthcare professionals (HCPs); the need for written contracts with HCOs, etc. As a National Society and member of IFCC and EFLM, the Lithuanian Society of Laboratory Medicine (LLMD) has created a fund dedicated to the continuous professional development of LLMD member HCPs. The fund, as an instrument for the ethical use of money, corresponds to the principles of the MedTech Code of Ethical Business Practice and is an example on how HCOs can implement it to ensure ethical communication between the IVD (In Vitro Diagnostics) industry, HCOs and their member HCPs. Scarce data exists on the level of MedTech acceptance and implementation among HCOs and HCPs, thus more effort has to be made to better communicate and consequently improve fair use of the funds received from the industry, and to improve the ethical behavior of HCPs.
欧洲医疗技术行业道德商业行为准则于2018年1月1日生效。它由医疗技术行业制定。该准则阐述了教育资助合理管理的重要性：公开披露提供的教育资助、会议符合会议审查系统的要求；向医疗保健组织（HCO）而非医疗保健专业人员（HCP）分配资助；与HCO签订书面合同的必要性等。作为国际临床化学和检验医学联合会（IFCC）及欧洲临床实验室和医学联合会（EFLM）的国家学会成员，立陶宛检验医学学会（LLMD）设立了一项基金，专门用于LLMD成员HCP的持续专业发展。该基金作为合理使用资金的一种手段，符合医疗技术行业道德商业行为准则的原则，是HCO如何实施该准则以确保体外诊断（IVD）行业、HCO及其成员HCP之间进行道德沟通的一个范例。关于HCO和HCP对医疗技术行业接受和实施程度的现有数据稀缺，因此必须做出更多努力，以更好地进行沟通，从而改善对从行业获得资金的合理使用，并改善HCP的道德行为。
